Peer navigation improves diagnostic follow-up after breast cancer screening among Korean American women: results of a randomized trial

Annette E Maxwell, Angela M Jo, Catherine M Crespi, Madhuri Sudan, Roshan Bastani, Annette E Maxwell, Angela M Jo, Catherine M Crespi, Madhuri Sudan, Roshan Bastani

Abstract

Objective: To test an intervention to increase adherence to diagnostic follow-up tests among Asian American women.

Methods: Korean American women who were referred for a diagnostic follow-up test (mainly diagnostic mammograms) and who had missed their follow-up appointment were eligible to participate in the study. Women from two clinics (n = 176) were randomly allocated to a usual care control arm or a peer navigator intervention arm. A 20-min telephone survey was administered to women in both study arms six months after they were identified to assess demographic and socio-economic characteristics and the primary outcome, self-reported completion of the recommended follow-up exam.

Results: Among women who completed the survey at six-month follow-up, self-reported completion of follow-up procedures was 97% in the intervention arm and 67% in the control arm (p < 0.001). Based on an intent-to-treat analysis of all women who were randomized and an assumption of no completion of follow-up exam for women with missing outcome data, self-reported completion of follow-up was 61% in the intervention arm and 46% in the usual care control arm (p < 0.069).

Conclusions: Our results suggest that a peer navigator intervention to assist Korean American women to obtain follow-up diagnostic tests after an abnormal breast cancer screening test is efficacious.

Figures

Fig. 1
Fig. 1
Flow chart

References

    1. Yabroff KR, Freedman A, Brown ML, Ballard-Barbash R, McNeel T, Taplin S. Trends in abnormal cancer screening results in the United States of America. J Med Screen. 2007;14(2):67–72. doi: 10.1258/096914107781261909.
    1. Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, et al. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States) Cancer Causes Control. 2006;17(1):29–38. doi: 10.1007/s10552-005-4558-y.
    1. Strzelczyk JJ, Dignan MB. Disparities in adherence to recommended followup on screening mammography: interaction of sociodemographic factors. Ethn Dis. 2002;12(1):77–86.
    1. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003;60(3):294–331. doi: 10.1177/1077558703254698.
    1. Mandelblatt J, Freeman H, Winczewski D, Cagney K, Williams S, Trowers R, et al. Implementation of a breast and cervical cancer screening program in a public hospital emergency department. Cancer Control Center of Harlem. Ann Emerg Med. 1996;28(5):493–498. doi: 10.1016/S0196-0644(96)70111-7.
    1. Rojas M, Mandelblatt J, Cagney K, Kerner J, Freeman H. Barriers to follow-up of abnormal screening mammograms among low-income minority women. Cancer Control Center of Harlem. Ethn Health. 1996;1(3):221–228. doi: 10.1080/13557858.1996.9961790.
    1. Peek ME, Han JH. Compliance and self-reported barriers to follow-up of abnormal screening mammograms among women utilizing a county mobile mammography van. Health Care Women Int. 2009;30(10):857–870. doi: 10.1080/07399330903066350.
    1. Allen JD, Shelton RC, Harden E, Goldman RE. Follow-up of abnormal screening mammograms among low-income ethnically diverse women: findings from a qualitative study. Patient Educ Couns. 2008;72(2):283–292. doi: 10.1016/j.pec.2008.03.024.
    1. Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health. 2008;17(6):923–930. doi: 10.1089/jwh.2007.0402.
    1. Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a US National Survey. Cancer Epidemiol Biomarkers Prev. 2004;13(5):723–732.
    1. Burack RC, Simon MS, Stano M, George J, Coombs J. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care. 2000;6(10):1102–1113.
    1. McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996;12(4):282–288.
    1. McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer. 1996;77(10):2070–2076. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2070::AID-CNCR16>;2-S.
    1. Michielutte R, Diseker RA, Young LD, May WJ. Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med. 1985;14(2):248–258. doi: 10.1016/0091-7435(85)90040-4.
    1. Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78(7):1395–1402. doi: 10.1002/(SICI)1097-0142(19961001)78:7<1395::AID-CNCR5>;2-K.
    1. Crane LA. Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ. 1996;11(3):164–173.
    1. Wujcik D, Fair AM. Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs. 2008;31(5):E16–E30. doi: 10.1097/01.NCC.0000305764.96732.45.
    1. Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004;101(5 suppl):1188–1200. doi: 10.1002/cncr.20506.
    1. Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–124. doi: 10.1007/s11524-007-9228-9.
    1. Ell K, Padgett D, Vourlekis B, Nissly J, Pineda D, Sarabia O, et al. Abnormal mammogram follow-up: a pilot study women with low income. Cancer Pract. 2002;10(3):130–138. doi: 10.1046/j.1523-5394.2002.103009.x.
    1. Ell K, Vourlekis B, Lee PJ, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007;44(1):26–33. doi: 10.1016/j.ypmed.2006.08.001.
    1. Crump SR, Shipp MP, McCray GG, Morris SJ, Okoli JA, Caplan LS, et al. Abnormal mammogram follow-up: do community lay health advocates make a difference? Health Promot Pract. 2008;9(2):140–148. doi: 10.1177/1524839907312806.
    1. Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359–367. doi: 10.1002/cncr.22354.
    1. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3(1):19–30.
    1. Burhansstipanov L, Wound DB, Capelouto N, Goldfarb F, Harjo L, Hatathlie L, et al. Culturally relevant “navigator” patient support. The native sisters. Cancer Pract. 1998;6(3):191–194. doi: 10.1046/j.1523-5394.1998.006003191.x.
    1. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300(22):1242–1245. doi: 10.1056/NEJM197905313002203.
    1. Bastani R, Glenn BA, Taylor VM, Chen MS, Jr, Nguyen TT, Stewart SL, et al. Integrating theory into community interventions to reduce liver cancer disparities: The health behavior framework. Prev Med. 2010;50(1–2):63–67. doi: 10.1016/j.ypmed.2009.08.010.
    1. Ma GX, Shive S, Tan Y, Gao W, Rhee J, Park M, et al. Community-based colorectal cancer intervention in underserved Korean Americans. Cancer Epidemiol. 2009;33(5):381–386. doi: 10.1016/j.canep.2009.10.001.
    1. Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, et al. Patient navigation: state of the art or is it science? Cancer. 2008;113(8):1999–2010. doi: 10.1002/cncr.23815.
    1. Freund KM, Battaglia TA, Calhoun E, Dudley DJ, Fiscella K, Paskett E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–3399. doi: 10.1002/cncr.23960.
    1. Engelstad LP, Stewart S, Otero-Sabogal R, Leung MS, Davis PI, Pasick RJ. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev Med. 2005;41(3–4):741–748. doi: 10.1016/j.ypmed.2005.06.003.
    1. Vourlekis B, Ell K, Padgett D. Evidence-based assessment in case management to improve abnormal cancer screen follow-up. Health Soc Work. 2005;30(2):98–106.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa